ObjectiveTo determine whether different molecular forms of hCG in serum and urine are elevated in preeclamptic pregnanciesMethodsForty-three pregnant women were studied: 25 preeclamptic women and 18 normotensive women. Immediately after blood and urine samples were collected, the protease inhibitors leupeptin (0.35mM) and phenanthroline (22 mM were added. Various molecular forms of hCG in serum (complete hCG, nonnicked hCG, complete free beta hCG) and in urine (complete hCG, beta-core fragment hCG) were measured by matched immunoassays with a common enzyme-labeled tracer antibody. The nicked hCG assay used a coating of beta-subunit monoclonal antibody with the addition of scavenger antibody to remove nonnicked hCG. Mann-WhitneyUtest andX2test were used for statistical analyses.ResultsPreeclamptic women had significantly higher median (range) levels of serum complete and nicked hCG than did normotensive women (3620 [850–12,0001 versus 2420 [310–4850] ng/mL,P= .024; and 102 [45–275] versus 71 [11–143] ng/mL,P= .010, respectively). Both median (range) urinary complete hCG-creatinine and beta-core fragmentcreatinine ratios were significantly higher in preeclamptic women that in normotensive women (37.6 [0.5–185] versus 11.3 [1.9–54],P= .013; and 11.8 [2–67] versus 5.3 [0.3–29],P= .009, respectively).ConclusionVarious molecular forms of hCG in serum and urine were significantly higher in preeclamptic than in normotensive pregnancies.